SCHEMBL30101944

SCHEMBL30101944

CC(CNC(=O)OC(C)(C)C)n1cnc2c(-c3cccnc3)nc(-c3ccc(Cl)cc3)cc2c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.36
CCNE2 O96020 1/20 0.36
CCNA2 P20248 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
CCNA1 P78396 1/20 0.36
PSD A5PKW4 3/20 0.35
ATR Q13535 2/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
MTOR P42345 1/20 0.34
PIK3CG P48736 1/20 0.34
PRKDC P78527 1/20 0.34
ATM Q13315 1/20 0.34
AAK1 Q2M2I8 1/20 0.34
IDO1 P14902 1/20 0.34
ACVR1B P36896 1/20 0.34
TGFBR1 P36897 1/20 0.34
ACVRL1 P37023 1/20 0.34
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23951122 0.91 EGLN1 (0.38) HTTCCNE2CCNA2CCNE1CDK2
SCHEMBL23950982 0.91 HTT (0.37) HTTCCNE2CCNA2CCNE1CDK2
SCHEMBL23950771 0.89 SCD (0.37) PSDATRPIK3CAPIK3CBMTOR
SCHEMBL23925833 0.89 EGLN1 (0.38) HTTPSDATRPIK3CAPIK3CB
SCHEMBL30101948 0.84 PSD (0.40) PSDATRPIK3CAPIK3CBMTOR
SCHEMBL23390225 0.84 PSD (0.40) PSDATRPIK3CAPIK3CBMTOR
SCHEMBL23390221 0.84 PSD (0.40) PSDATRPIK3CAPIK3CBMTOR
SCHEMBL23950302 0.84 PSD (0.36) PSDATRPIK3CAPIK3CBMTOR
SCHEMBL23950594 0.83 PSD (0.40) PSDATRPIK3CAPIK3CBMTOR
SCHEMBL23950299 0.83 PSD (0.37) PSDATRPIK3CAPIK3CBMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115443276-B Pyridopyrimidinone derivatives and their use as arene receptor modulators 东亚ST株式会社 2025-04-18 CN disclosed
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2023-05-11 US disclosed
EP-4136088-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS Dong-A ST Co., Ltd. (KR) 2023-02-22 EP disclosed
CN-115443276-A Pyridopyrimidinone derivatives and their use as modulators of aromatic hydrocarbon receptors 东亚ST株式会社 2022-12-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS AHR, ARNT, AIPL1 HTT 855/4885CCNE2 2713/4885CCNA2 2972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.